Come up with a name for your new list and we'll add to it:
EnzymeRx raised a round of funding on , . Investors include
Pequot Capital Mangement.
EnzymeRx is a private, clinical stage biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications in which hyperuricemia plays a causativ…